Skip to main content
. 2019 Jan 8;11(1):56. doi: 10.3390/cancers11010056

Figure 4.

Figure 4

The recurrence rates in patients stratified by their CTC and carcinoembryonic antigen (CEA) counts, and their combination. (A) Recurrence rates of different CTC levels in non-metastatic patients; (B) recurrence rates of different CEA levels in non-metastatic patients; (C) recurrence rates of different CTC and CEA levels in non-metastatic patients; (D) recurrence rates of different CTC levels in metastatic patients; (E) recurrence rates of different CEA levels in metastatic patients; (F) recurrence rates of different CTC and CEA levels in metastatic patients.